Search results
Results from the WOW.Com Content Network
5-Methoxy-7,N,N-trimethyltryptamine (5-MeO-7,N,N-TMT, 5-MeO-7-TMT), is a tryptamine derivative which acts as a partial agonist at the 5-HT 2 serotonin receptors, with an EC 50 of 63.9 nM and an efficacy of 66.2% at 5-HT 2A (vs 5-HT), and weaker activity at 5-HT 2B and 5-HT 2C. [1] [2] [3] In animal tests, both 7,N,N-TMT and 5-MeO-7,N,N-TMT ...
5-Methoxy-2,N,N-trimethyltryptamine (5-MeO-2,N,N-TMT, 5-MeO-TMT) is a psychoactive drug of the tryptamine chemical class which acts as a psychedelic.It was first synthesized by Alexander Shulgin and reported in his book TiHKAL ("Tryptamines i Have Known And Loved").
7,N,N-trimethyltryptamine (7-methyl-DMT, 7-TMT), is a tryptamine derivative which acts as an agonist of 5-HT 2 receptors. [1] [2] [3] In animal tests, both 7-TMT and its 5-methoxy derivative 5-MeO-7-TMT produced behavioural responses similar to those of psychedelic drugs such as DMT, but the larger 7-ethyl and 7-bromo derivatives of DMT did not produce psychedelic responses despite having ...
5-Methoxytryptamine (5-MT, 5-MeO-T, or 5-OMe-T), also known as serotonin methyl ether or O-methylserotonin and as mexamine, is a tryptamine derivative closely related to the neurotransmitters serotonin and melatonin. [3]
5-MeT is known to act as a potent serotonin 5-HT 2A receptor full agonist, with an EC 50 Tooltip half-maximal effective concentration of 6.00 nM and an E max Tooltip maximal efficacy of 100%. [1] In addition, it is known to be a ligand of the serotonin 5-HT 1A [3] and 5-HT 2B receptors [2] and an agonist of the serotonin 5-HT 1D [4] [5] and 5 ...
5-MeO-DMT is a potent and fast-acting psychedelic, which is naturally produced by the Sonoran Desert toad as well as some species of plants. Its short duration –from 20 minutes to one hour– is ...
[1] [2] [3] It is also the N,N-dimethylated derivative of 5-methoxy-α-methyltryptamine (5-MeO-αMT or α,O-DMS) and the N-methylated derivative of 5-methoxy-α,N-dimethyltryptamine (5-MeO-α,N-DMT or α,N,O-TMS). [1] [2] [3] The compound was described by Alexander Shulgin in TiHKAL as a putative psychedelic drug, but does not appear to have ...
5,N,N-trimethyltryptamine (5,N,N-TMT; 5-TMT) is a tryptamine derivative that is a psychedelic drug. It was first made in 1958 by Edwin H. P. Young. [1] In animal experiments it was found to be in between DMT and 5-MeO-DMT in potency [2] [3] which would suggest an active dosage for humans in the 20–60 mg range.